CONNEQT Health Limited (ASX:CQT)
Australia · Delayed Price · Currency is AUD 0.0280
0.00 (0.00%)
At close: Mar 17, 2026
CONNEQT Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 4.2 | 3.55 | 10.91 | 4.6 | 4.07 | 4.98 |
Other Revenue | 1.6 | 2.5 | 1.91 | 1.09 | 0.67 | 0.53 |
| 5.8 | 6.05 | 12.81 | 5.69 | 4.74 | 5.52 | |
Revenue Growth (YoY) | 1.30% | -52.76% | 125.14% | 20.12% | -14.11% | 15.45% |
Cost of Revenue | 2.14 | 1.82 | 0.8 | 0.91 | 1.01 | 0.9 |
Gross Profit | 3.66 | 4.23 | 12.02 | 4.79 | 3.73 | 4.61 |
Selling, General & Admin | 14.45 | 13.81 | 14 | 14.17 | 11.38 | 5.98 |
Research & Development | 1.35 | 2.21 | 2.49 | 3.91 | 2.38 | 1.75 |
Amortization of Goodwill & Intangibles | 0.21 | 0.1 | 0.01 | - | - | - |
Other Operating Expenses | - | - | - | - | - | 0.35 |
Operating Expenses | 16.32 | 17.03 | 16.65 | 20.14 | 15.77 | 9.48 |
Operating Income | -12.66 | -12.8 | -4.63 | -15.35 | -12.04 | -4.86 |
Interest Expense | -0.44 | -0.66 | -1.18 | -0.41 | -0.23 | -0.27 |
Interest & Investment Income | 0 | 0 | 0.27 | 0.26 | 0.43 | 0.26 |
Currency Exchange Gain (Loss) | -0.01 | 0.05 | 0.01 | 0.07 | 0.3 | -0.53 |
Other Non Operating Income (Expenses) | - | - | -0.44 | -3.45 | -0.28 | 0.01 |
EBT Excluding Unusual Items | -13.11 | -13.41 | -5.98 | -18.89 | -11.81 | -5.4 |
Gain (Loss) on Sale of Investments | -4.1 | -4.79 | -0.79 | - | - | -0.06 |
Other Unusual Items | - | - | - | - | - | 0.29 |
Pretax Income | -17.21 | -18.19 | -6.77 | -18.89 | -11.81 | -5.16 |
Net Income | -17.21 | -18.19 | -6.77 | -18.89 | -11.81 | -5.16 |
Net Income to Common | -17.21 | -18.19 | -6.77 | -18.89 | -11.81 | -5.16 |
Shares Outstanding (Basic) | 487 | 354 | 201 | 130 | 103 | 87 |
Shares Outstanding (Diluted) | 487 | 354 | 201 | 130 | 103 | 87 |
Shares Change (YoY) | 75.92% | 76.59% | 54.14% | 26.31% | 18.02% | 20.09% |
EPS (Basic) | -0.04 | -0.05 | -0.03 | -0.15 | -0.11 | -0.06 |
EPS (Diluted) | -0.04 | -0.05 | -0.03 | -0.15 | -0.12 | -0.06 |
Free Cash Flow | -9.49 | -10.92 | -7.84 | -12.05 | -9.57 | -4.04 |
Free Cash Flow Per Share | -0.02 | -0.03 | -0.04 | -0.09 | -0.09 | -0.05 |
Gross Margin | 63.11% | 69.92% | 93.77% | 84.08% | 78.75% | 83.66% |
Operating Margin | -218.41% | -211.42% | -36.16% | -269.73% | -254.02% | -88.13% |
Profit Margin | -296.89% | -300.58% | -52.80% | -331.86% | -249.25% | -93.54% |
Free Cash Flow Margin | -163.72% | -180.45% | -61.19% | -211.80% | -202.02% | -73.31% |
EBITDA | -12.4 | -12.64 | -4.56 | -15.28 | -11.97 | -4.71 |
EBITDA Margin | -213.92% | -208.79% | -35.59% | -268.46% | -252.71% | -85.47% |
D&A For EBITDA | 0.26 | 0.16 | 0.07 | 0.07 | 0.06 | 0.15 |
EBIT | -12.66 | -12.8 | -4.63 | -15.35 | -12.04 | -4.86 |
EBIT Margin | -218.41% | -211.42% | -36.16% | -269.73% | -254.02% | -88.13% |
Revenue as Reported | 5.79 | 6.11 | 13.09 | 6.02 | 5.47 | 6.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.